TSH Receptor
Read More about this categoryShow Less
The thyrotropin receptor (TSHR), one of the primary antigens in autoimmune thyroid disease, is a target of both antigen-specific T cells and antibodies in patients with this condition. Autoantibodies to the TSHR (TSHR-Ab) act as thyroid stimulating factor (TSH) agonists in autoimmune hyperthyroidism (Robert Graves disease) but as TSH antagonists in autoimmune hypothyroidism (Hashimoto thyroiditis). The TSHR antigen is primarily expressed in the epithelial cells of the thyroid follicles, but TSHR mRNA and protein have been reported in a variety of cell types, some of which show evidence of receptor activity.
TSH receptor (TSHR) plays an important role in the pathogenesis of thyroid disease, a TSHR antagonist could be a novel treatment.
TSH, acting through the TSH receptor, is the major stimulator of thyroid cell growth, differentiation and function.
Products Related to TSH Receptor(10)
- GC19543NCGC00379308CAS: 662164-09-2Purity: >98%
NCGC00379308 is a positive allosteric modulator for thyrotropin receptor (TSHR), which initiates translocation of β-Arr 1 by direct TSHR activation and potentiates TSH-mediated preosteoblast differentiation in vitro.
- GC26016TSHR antagonist S37CAS: 1217616-61-9Purity: >98%
TSHR antagonist S37 is a selective and competitive antagonist of the thyrotropin receptor (TSHR).
- GC62506TSHR antagonist S37bCAS: 2143452-22-4Purity: >99.00%
TSHR antagonist S37b is the less effective enantiomer of TSHR antagonist S37a.
- GC62519TSHR antagonist S37aCAS: 2143452-20-2Purity: >99.00%
TSHR antagonist S37a is a highly selective thyrotropin receptor (TSHR) antagonist, with potential for the treatment of Graves' orbitopathy.
- GC64079NCGC00229600CAS: 1338824-20-6Purity: >99.00%
NCGC00229600 is an allosteric inverse agonist of thyrotropin receptor (TSHR).
- GC65946VA-K-14 hydrochlorideCAS: 1171341-19-7Purity: >98%
VA-K-14 hydrochloride is a specific thyroid-stimulating hormone receptor (TSHR) antagonist (IC50= 12.3 μM).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC12956 | ML224 | 1338824-21-7 | >98.50% | |
selective TSHR inverse agonist | ||||
| GC19543 | NCGC00379308 | 662164-09-2 | >98% | |
NCGC00379308 is a positive allosteric modulator for thyrotropin receptor (TSHR), which initiates translocation of β-Arr 1 by direct TSHR activation and potentiates TSH-mediated preosteoblast differentiation in vitro. | ||||
| GC26016 | TSHR antagonist S37 | 1217616-61-9 | >98% | |
TSHR antagonist S37 is a selective and competitive antagonist of the thyrotropin receptor (TSHR). | ||||
| GC31490 | ML-109 | 1186649-91-1 | >99.00% | |
ML-109 is a potent and full thyroid stimulating hormone receptor (TSHR) agonist, with an EC50 of 40 nM. | ||||
| GC32423 | Org41841 | 301847-37-0 | >99.00% | |
Org41841 is a partial agonist of both luteinizing hormone/chorionic gonadotropin receptor (LHCGR) and thyroid-stimulating hormone receptor (TSHR) with EC50s of 0.2 and 7.7 μM, respectively. | ||||
| GC62506 | TSHR antagonist S37b | 2143452-22-4 | >99.00% | |
TSHR antagonist S37b is the less effective enantiomer of TSHR antagonist S37a. | ||||
| GC62519 | TSHR antagonist S37a | 2143452-20-2 | >99.00% | |
TSHR antagonist S37a is a highly selective thyrotropin receptor (TSHR) antagonist, with potential for the treatment of Graves' orbitopathy. | ||||
| GC64079 | NCGC00229600 | 1338824-20-6 | >99.00% | |
NCGC00229600 is an allosteric inverse agonist of thyrotropin receptor (TSHR). | ||||
| GC65946 | VA-K-14 hydrochloride | 1171341-19-7 | >98% | |
VA-K-14 hydrochloride is a specific thyroid-stimulating hormone receptor (TSHR) antagonist (IC50= 12.3 μM). | ||||
| GC71446 | SYD5115 | - | - | |
SYD5115 is an orally available TSH-R antagonist. | ||||
